As a complementary analysis, seeking additional evidence for the observed relationship between PTGS1 and PTGS2 expression in CML clinical samples, in vitro tests were performed to evaluate the expression of both genes in the K562 cell line when exposed to Imatinib. The gene discussed is PTGS1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.